Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125371201 | 12537120 | 1 | I | 201604 | 20160629 | 20160707 | 20160707 | EXP | CH-JNJFOC-20160626120 | JANSSEN | 28.00 | YR | A | F | Y | 85.20000 | KG | 20160707 | PH | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125371201 | 12537120 | 1 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | N | 21976 | 800 | MG | TABLETS | QD | ||||||
| 125371201 | 12537120 | 2 | I | FLUCONAZOL SANDOZ | FLUCONAZOLE | 1 | Oral | 0 | 400 | MG | UNSPECIFIED | QD | |||||||
| 125371201 | 12537120 | 3 | I | NORVIR | RITONAVIR | 1 | Oral | 0 | 100 | MG | CAPSULES | QD | |||||||
| 125371201 | 12537120 | 4 | I | VIMPAT | LACOSAMIDE | 1 | Oral | Y | 0 | FILM COATED TABLET | |||||||||
| 125371201 | 12537120 | 5 | I | VIMPAT | LACOSAMIDE | 1 | Oral | Y | 0 | 150 | MG | FILM COATED TABLET | BID | ||||||
| 125371201 | 12537120 | 6 | I | VIMPAT | LACOSAMIDE | 1 | Oral | Y | 0 | 200 | MG | FILM COATED TABLET | BID | ||||||
| 125371201 | 12537120 | 7 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 0 | 1 | DF | FILM COATED TABLET | QD | |||||||
| 125371201 | 12537120 | 8 | C | VALCYTE | VALGANCICLOVIR HYDROCHLORIDE | 1 | Oral | 0 | 900 | MG | FILM COATED TABLET | QD | |||||||
| 125371201 | 12537120 | 9 | C | LAMICTAL | LAMOTRIGINE | 1 | Oral | 0 | TABLETS | ||||||||||
| 125371201 | 12537120 | 10 | C | LAMICTAL | LAMOTRIGINE | 1 | Oral | 0 | 100 | MG | TABLETS | BID | |||||||
| 125371201 | 12537120 | 11 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | 1 | DF | FILM COATED TABLET | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125371201 | 12537120 | 1 | HIV infection CDC category C |
| 125371201 | 12537120 | 2 | HIV infection CDC category C |
| 125371201 | 12537120 | 3 | HIV infection CDC category C |
| 125371201 | 12537120 | 4 | Epilepsy |
| 125371201 | 12537120 | 5 | Epilepsy |
| 125371201 | 12537120 | 6 | Epilepsy |
| 125371201 | 12537120 | 7 | HIV infection CDC category C |
| 125371201 | 12537120 | 9 | Epilepsy |
| 125371201 | 12537120 | 10 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125371201 | 12537120 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125371201 | 12537120 | Ataxia | |
| 125371201 | 12537120 | Drug interaction | |
| 125371201 | 12537120 | Gait disturbance | |
| 125371201 | 12537120 | Headache | |
| 125371201 | 12537120 | Nystagmus | |
| 125371201 | 12537120 | Toxicity to various agents | |
| 125371201 | 12537120 | Vertigo | |
| 125371201 | 12537120 | Vision blurred | |
| 125371201 | 12537120 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125371201 | 12537120 | 1 | 201604 | 0 | ||
| 125371201 | 12537120 | 2 | 201604 | 0 | ||
| 125371201 | 12537120 | 3 | 201604 | 0 | ||
| 125371201 | 12537120 | 6 | 20160426 | 0 |